ulcerative colitis
FDA Approves Risankizumab for Ulcerative Colitis
The FDA has approved risankizumab (Skyrizi, AbbVie) for patients with moderate to severe ulcerative colitis.
JULY 8, 2024
High Complication Rate After Early Ileostomy Closure Prompts Study’s Halt
In a prematurely stopped trial, ulcerative colitis patients with ileal pouch–anal anastomosis who underwent ...
JUNE 28, 2022
Study Shows Benefit for Appendectomy in Ulcerative Colitis Patients
Cleveland—For two decades, studies have shown an inverse relationship between appendectomy and ulcerative ...
JANUARY 2, 2020
Online CRC Risk Tool Guides Care for UC Patients
An online tool for patients with ulcerative colitis and low-grade dysplasia can help them consider their options ...
SEPTEMBER 10, 2018
Online CRC Risk Tool Guides Care For Ulcerative Colitis Patients
Vienna—A novel risk assessment tool for patients with colorectal cancer and ulcerative colitis and low-grade ...
APRIL 24, 2018
